CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Grant or award Director acquired 14,285 shares (grant or award)
- 4 Grant or award Director acquired 14,285 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 3,794 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 3,522 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Grant or award Director acquired 1,962 shares (grant or award)
- 4 Grant or award Director acquired 2,355 shares (grant or award)
- 4 Grant or award Director acquired 1,727 shares (grant or award)
- 4 Grant or award Director acquired 1,962 shares (grant or award)
- 4 Open-market buy EVP and CFO bought 15,000 shares at $16.10 ($241,470)
- 4 Open-market buy CHAIRMAN & CEO bought 30,000 shares at $16.05 ($481,500)
- 4 Open-market buy Director bought 10,000 shares at $15.34 ($153,400)
- 4 Grant or award SVP, CHIEF ACCOUNTING OFFICER acquired 10,654 shares (grant or award)
- 4 Grant or award EVP, COMPANY GROUP CHAIRMAN acquired 22,162 shares (grant or award)
- 4 Grant or award EVP AND GENERAL COUNSEL acquired 20,457 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 59,667 shares (grant or award)
- 4 Grant or award CHAIRMAN & CEO acquired 113,652 shares (grant or award)
- 4 Open-market buy Director bought 7,066,629 shares at $15.40 ($108,826,087)
- 4/A Shares withheld for taxes EVP, COMPANY GROUP CHAIRMAN gave up 1,264 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHIEF ACCOUNTING OFFICER gave up 1,826 shares (to pay taxes)
Page 26 of 61 · 1,214 filings